Disitamab vedotin (RC48) is an antibody-drug conjugate (ADC) and a HER2-targeted cytotoxic agent, consisting of an anti-HER2 monoclonal antibody conjugated to MMAE via a cleavable linker, used for the treatment of HER2-expressing solid tumors including gastric cancer, breast cancer, and urothelial carcinoma.
Purity:
95.00%
CAS Number:
[2136633-23-1]
Target:
Antibody-Drug Conjugates (ADCs)|||EGFR
T39595
* VAT and and shipping costs not included. Errors and price changes excepted